Pathos Communications Reports 14% Revenue Increase and 31% Growth in Adjusted EBITDA in H1 2026 as a Public Company

Strong Double-Digit Revenue Growth and Enhanced Profitability in H1 2026

Pathos Communications reported US$7.3 million in revenue for the first half of 2026, a 14% increase from US$6.4 million in H1 2025. This growth reflects the company’s focus on product innovation and effective scaling of sales channels since its December 2025 AIM listing. The Board noted that this progress was achieved while continuing investments in growth initiatives, with full benefits expected in the second half of 2026.

Adjusted EBITDA rose 31% to US$1.7 million in H1 2026 from US$1.3 million in H1 2025, demonstrating improved operational leverage and profitability despite new PLC-related costs from December 2025. The disparity between revenue growth (14%) and EBITDA growth (31%) highlights Pathos’s operational efficiency and disciplined cost control as it expands its commercial operations. This margin improvement indicates that investments in infrastructure and technology are beginning to enhance profitability.

Robust Cash Position and 80% Growth in Customer Cash Receipts

As of 30 June 2026, Pathos held net cash of US$5.9 million, slightly below the US$6.2 million at 31 December 2025, despite significant investments in sales management and growth initiatives during H1 2026. This strong cash position reflects the impact of enhanced credit checks and cash collection processes implemented in H1 2025, which improved the timing and quality of customer payments.

Cash receipts from customers increased by 80% in H1 2026 compared to the same period in 2025, underscoring the success of credit and collections improvements. Bad debts accounted for approximately 4% of revenue, reflecting disciplined credit management. This combination of stronger cash flow and controlled credit losses demonstrates Pathos’s effective management of payment volatility while sustaining aggressive growth, providing investors with confidence in revenue sustainability and self-funded expansion.

Repeat Customer Revenue Surges to 36% of Sales, Signaling Stronger Commercial Execution

Repeat customer revenue rose sharply to approximately 36% of total revenue in H1 2026 from 16% in H1 2025, a 225% increase in proportion. This growth highlights Pathos’s successful strategy of expanding existing client engagements and improving retention. Management expects this trend to continue, indicating confidence in customer loyalty and expansion.

This shift toward repeat business reduces reliance on new customer acquisition, typically enhancing lifetime customer value and unit economics. Although the announcement does not specify customer counts, the revenue share increase shows that existing client relationships are growing faster than overall revenue, providing resilience against acquisition challenges and affirming the appeal of Pathos’s offerings to SME and micro-SME clients.

Record US$0.7 Million Contract Secured with Leading Non-Profit Consulting Firm

On 26 May 2026, Pathos signed its largest contract to date: a 12-month deal worth US$0.7 million with a major non-profit consulting firm. This contract, representing about 9.6% of H1 2026 revenue, marks a milestone in Pathos’s ability to secure enterprise-scale engagements. Revenue and Adjusted EBITDA from this contract will be recognized evenly across FY 2026 and FY 2027.

This contract backlog provides visibility into FY 2027 revenue and supports sustained growth momentum. The commitment from a tier-one non-profit consulting client validates Pathos’s value proposition and capability at scale, potentially accelerating its move into larger enterprise markets beyond its core SME base. Investors may view this as evidence of expanding market reach.

New Sales Management Structure Drives 30% Monthly Growth in New Clients

Pathos introduced a new sales team management structure in H1 2026, creating focused teams to scale commercial operations. This restructuring has resulted in approximately 30% month-on-month growth in new client sign-ups since inception, indicating strong commercial momentum. If sustained, this growth rate would significantly accelerate customer acquisition.

The timing indicates that by the H1 2026 update (27 July 2026), benefits were already evident, supporting the Board’s confidence in meeting FY 2026 guidance of US$14.0 million revenue and US$4.0 million Adjusted EBITDA. The full six-month impact in H2 2026 is expected to drive further acceleration.

Geographic Expansion and Early Growth in APAC Operations

Pathos’s client base now spans over 80 countries, with a newly launched dedicated Asia-Pacific (APAC) operation showing early positive signs. This strategic investment targets the large SME populations in APAC markets, where digital PR adoption is growing rapidly. Establishing local infrastructure signals management’s conviction in the region’s market potential.

While specific APAC revenue or customer data were not disclosed, early traction suggests geographic diversification is reducing reliance on mature Western markets and positioning Pathos to benefit from SME digital transformation across Asia-Pacific. Investors should watch for future updates detailing APAC performance as the operation matures, aligning with the company’s mission to serve over 400 million SMEs globally.

Pressella AI Platform Demonstrates Sevenfold Sales Development Efficiency Over Humans

Initial testing of Pressella, Pathos’s proprietary AI "virtual publicist," showed it achieves at least a 7x success rate compared to human colleagues in sales development, a trend that continues. Since appointing Scott Feltham as Chief Technology Officer, the company has expanded Pressella’s training scope and business applications. This AI tool addresses scalability challenges in traditional PR client development and account management, potentially reducing customer acquisition costs significantly.

Pathos also progressed its PathosMind AI tool, with both expected to reach general availability in H1 2027. Although current usage metrics were not disclosed, the CTO appointment and expanded training investment demonstrate strong management commitment. These AI platforms are key to Pathos’s competitive advantage and margin expansion potential.

Generative Engine Optimisation Poised to Capitalize on Doubling Global PR Spend by 2027

Pathos identified Generative Engine Optimisation (GEO) as a major growth opportunity. GEO involves structuring customer publications for AI search tools like ChatGPT to process, summarize, and cite effectively, adapting to AI-driven information discovery. Gartner research forecasts that GEO evolution will double global PR expenditure by 2027.

This external analyst insight underscores GEO’s potential as a structural growth driver. While current GEO revenue and pipeline details were not provided, its prominence in the update signals management’s focus. Investors should monitor forthcoming disclosures for GEO-related traction, which could fuel significant growth in 2027 and beyond.

Strategic 24-Month Partnership with Top US News Publisher Enhances Premium Access

In H1 2026, Pathos entered a 24-month strategic agreement with one of the "Big Three" US news periodicals, establishing a tier-one publisher relationship. The deal requires no minimum commitment from Pathos, while the publisher agreed to publish up to 2,000 articles annually for Pathos clients. This arrangement grants Pathos premium publishing access without upfront costs or revenue guarantees, benefiting both parties.

This capability significantly enhances Pathos’s offering to SMEs, which typically lack access to high-profile distribution channels. Additionally, Pathos expanded its product suite in H1 2026 to include podcast services and book publishing, diversifying revenue streams beyond traditional news article placements and broadening its media distribution portfolio.

Board Confirms Confidence in FY 2026 Targets and Anticipates H2 Growth Acceleration

The Board reaffirmed confidence in meeting FY 2026 market expectations of US$14.0 million revenue and US$4.0 million Adjusted EBITDA. These targets imply H2 2026 revenue of approximately US$6.7 million (a 10% decrease from H1) and Adjusted EBITDA of US$2.3 million (a 35% increase from H1). However, the Board also expects accelerated growth in H2, suggesting actual figures may exceed these forecasts.

Investments made in H1 2026 are projected to deliver full benefits in H2, and management continues exploring value-accretive M&A opportunities alongside organic growth. Interim results scheduled for September 2026 will provide investor insight into H1 guidance accuracy and early H2 trends. The announcement maintains a constructive tone, emphasizing the positive positioning from H1 investments rather than operational challenges.